Clinical trials
Active, not recruiting Phase 1/2 Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 5 |
| 2019 | 7 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 10 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Daiichi Sankyo | 2 |
| Eli Lilly and Company | 2 |
| M.D. Anderson Cancer Center | 2 |
| A2 Biotherapeutics Inc. | 1 |
| Accendatech USA Inc. | 1 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| BioAtla, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 43 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Neoplasm Metastasis | 7 |
| Lung Neoplasms | 6 |
| Melanoma | 6 |
| Colonic Neoplasms | 4 |
| Colorectal Neoplasms | 4 |
| Recurrence | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Hepatocellular | 3 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.